Clinical MedicineUpdated Aug 20, 2026Version v1
Reviewed milestones, validation shifts, standards, datasets, and debates linked to public evidence.
Evidence from The Nephron journals/Nephron journals indicates that Organoids are complex 3D structures resembling organs, generated in vitro from stem cells or progenitor cells. This is tracked as a clinical because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.
Evidence from Cancer Research indicates that Developed a 3D organoid culture system for glioblastoma that supports long-term growth and expansion. This is tracked as a standard because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.
Evidence from Proceedings of the National Academy of Sciences indicates that Developed a multisensor-integrated organs-on-chips platform. This is tracked as a clinical because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.
Evidence from Journal of Pharmaceutical Analysis indicates that Microfluidic chip technologies offer new approaches for drug analysis. This is tracked as a review because it changes how Organoids and organs-on-a-chip is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.
Evidence from Nature Communications indicates that Decellularized tissue ECM hydrogels support the formation and growth of endodermal organoids. This is tracked as a clinical because it changes how Organoids and organs-on-a-chip is understood, validated, or applied. It is supported by 4 papers in the same timeline signal.
Evidence from Frontiers in Molecular Biosciences indicates that 3D cell culture can mimic in vivo cell environments more accurately than 2D. This is tracked as a review because it changes how Organoids and organs-on-a-chip is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.
Evidence from Communications Biology indicates that Matrigel, a common component in organoid culture, is complex and poorly defined. This is tracked as a review because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.
Evidence from Science indicates that PDOs exhibit high phenotypic and genotypic similarity to original patient tumors. This is tracked as a clinical because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.
Evidence from Advanced Materials indicates that Hydrogels are functional biomaterials increasingly used in organoids and OOC systems. This is tracked as a review because it changes how Organoids and organs-on-a-chip is understood, validated, or applied. It is supported by 2 papers in the same timeline signal.
Evidence from Advanced Biology indicates that Organoids and organs-on-a-chip are promising 3D cell culture models for studying physiology and disease. This is tracked as a standard because it changes how Organoids and organs-on-a-chip is understood, validated, or applied.